Saturday, March 14, 2026




In Detail Full day, Saturday, March 14, 2026, Timezone: America/Chicago


A new triple negative breast cancer target: Why HORMAD1 could guide treatment choices / Medical Express

medicalxpress - A gene that is typically active only in reproductive cells may hold the key to new treatments for triple negative breast cancer, according to new research published in the journal Nature Communications. Scientists from the Breast Cancer Now Toby Robins Re…

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch


Saturday, March 14, 2026, 11:21 pm / permalink 20776 / 4 stories in 43 hrs


Alfasigma Pays $300M for Rights to GSK Rare Liver Disease Drug On Track for FDA Decision / MedCity

Frank Vinluan / medcitynews - GSK licensed to Alfasigma global rights to linerixibat, a drug developed to treat the rare liver disease primary biliary cholangitis (PBC). The move follows Alfasigma’s 2025 voluntary market withdrawal of Ocaliva, a PBC drug that had sparked safety concer…

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment #healthcarefinance


Saturday, March 14, 2026, 8:21 pm / permalink 20771 / 2 stories in 46 hrs


Roche’s big hope breast cancer drug fails in crucial first-line trial / Endpoints

Elizabeth Cairns / endpoints - Roche’s breast cancer pill, which the company recently said had the potential to become its biggest-ever selling drug, has failed in what is arguably its most important Phase 3 trial. The persevERA ...

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch


Saturday, March 14, 2026, 7:21 pm / permalink 20770 / 5 stories in 47 hrs


‘They Need Each Other’: Why Hims & Hers and Novo Nordisk Made Up / MedCity

Marissa Plescia / medcitynews - Novo Nordisk dropped its lawsuit against Hims & Hers and launched a new collaboration. The deal is advantageous for both companies, experts say.The post ‘They Need Each Other’: Why Hims & Hers and Novo Nordisk Made Up appeared first on MedCity News.

#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #digitalhealth #healthcarefinance #supplychain


Saturday, March 14, 2026, 2:22 pm / permalink 20763 / 3 stories in 2 days


Fitch upgrades UCHealth’s rating to ‘AA+’ / Beckers

Andrew Cass / beckershospitalreview - Aurora, Colo.-based UCHealth’s credit rating was upgraded to “AA+” from “AA” by Fitch. The upgrade reflects the health system’s very strong financial profile, benefiting from its market position in a growing service area and a long track record of robust …

#healthcare #publichealth #governmentpolicy #digitalhealth #medicaldevices #oncology #hospitaloperations #cancerresearch


Saturday, March 14, 2026, 2:22 pm / permalink 20762 / 5 stories in 2 days


Antonio Calles: RECITE Trial Findings on Romiplostim for Chemotherapy-Induced Thrombocytopenia / OncoDaily

oncodaily - Antonio Calles, Medical Oncologist at Hospital General Universitario Gregorio Marañón and faculty member of the Lung and Other Thoracic Tumours faculty group of the ESMO, shared a post by NEJM, […]

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch


Saturday, March 14, 2026, 12:23 pm / permalink 20760 / 2 stories in 2 days


The appendix evolved at least 32 times across 361 species, so it's 'unlikely to be a useless evolutionary accident,' research finds / LiveScience

livescience - Two researchers explore the evolutionary history of the appendix and its role in human health.

#healthcare #wildlife #animalhealth


Saturday, March 14, 2026, 11:22 am / permalink 20758 / 2 stories in 2 days


Spousal loss linked to higher risk of dementia and mortality among men, but not women / Medical Express

medicalxpress - The loss of a spouse is an incredibly emotional and stressful experience, and as populations continue to live longer lives, more couples will experience this distress. But spousal bereavement appears to affect genders differently, according to a new study…

#none


Saturday, March 14, 2026, 9:21 am / permalink 20752 / 2 stories in 2 days


Personalized Support Program Improves Smoking Cessation for Cervical Cancer Survivors – UCLA Health / OncoDaily

oncodaily - UCLA study shows program doubles quit rates for women and offers a cost-effective approach A new study led by UCLA researchers suggests that a personalized counseling program can significantly help […]

#healthcare #publichealth #oncology #behavioralhealth #cancerresearch


Saturday, March 14, 2026, 6:21 am / permalink 20747 / 2 stories in 2 days


Grail names new CEO as Bob Ragusa retires / Endpoints

Jared Whitlock / endpoints - Grail on Thursday announced that its CEO, Bob Ragusa, will retire and is handing the reins to its current president Josh Ofman. The cancer screening company said the move was the culmination of long-term succession ...

#healthcare #biotech #medicaldevices #oncology #healthcarefinance #cancerresearch


Saturday, March 14, 2026, 4:21 am / permalink 20744 / 5 stories in 2 days


Measles outbreaks could fuel rise in fatal complication, physicians warn / Beckers

Mackenzie Bean / beckershospitalreview - As measles continues spreading across the U.S. at a pace not seen in decades, physicians are warning about a rare but often fatal neurological complication that can emerge years after initial infection, KFF Health News reported March 13. Subacute sclerosi…

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety #infectiousdisease


Saturday, March 14, 2026, 2:21 am / permalink 20742 / 8 stories in 2 days


Vanderbilt Health president, CEO to retire / Beckers

Paige Twenter / beckershospitalreview - Jeff Balser, MD, PhD, president and CEO of Vanderbilt Health and dean of Vanderbilt University’s school of medicine, plans to retire from both roles Dec. 31, according to a March 12 news release from the Nashville, Tenn.-based organizations. During his 17…

#healthcare #hospitaloperations #healthcarefinance #researchfunding


Saturday, March 14, 2026, 2:21 am / permalink 20741 / 2 stories in 2 days


AMA: Physicians' use of AI doubled from 2023 to 2026 / Fierce

fiercehealthcare - A survey fielded earlier this year found 81% of doctors use AI in a professional context, with an average of 2.3 use cases per physician. Respondents were largely bullish on the technology's ability to boost clinical care and work efficiency, but still ha…

#healthcare #publichealth #governmentpolicy #digitalhealth #hospitaloperations #cybersecurity


Saturday, March 14, 2026, 1:21 am / permalink 20740 / 14 stories in 2 days


Ipsen pulls cancer drug Tazverik from market over safety risks / Endpoints

Nicole DeFeudis / endpoints - Ipsen is pulling its cancer drug Tazverik from the market after an independent data monitoring committee found safety concerns in a confirmatory trial. The committee reported cases of secondary cancers that begin in blood-forming tissue ...

#healthcare #pharmaceuticals #biotech #drugdevelopment #fda #productrecall #oncology #cancerresearch


Saturday, March 14, 2026, 12:23 am / permalink 20738 / 3 stories in 2 days


Eliquis may be safer than Xarelto for patients with deep blood clots: Study / Beckers

Ella Jeffries / beckershospitalreview - Patients taking blood thinner Eliquis had a lower risk of clinically relevant bleeding than those taking Xarelto, a recent study found. Researchers enrolled 2,760 patients with venous thrombosis — blood clots in the veins of the legs or lungs — and random…

#healthcare #pharmaceuticals #publichealth #drugdevelopment


Saturday, March 14, 2026, 12:23 am / permalink 20737 / 2 stories in 2 days


Flu vaccines didn't work that well in the US, officials find / Medical Express

medicalxpress - As the U.S. flu season winds down, health officials say the flu vaccine didn't work very well, with one of its worst effectiveness rates in more than a decade.

#healthcare #pharmaceuticals #publichealth #drugdevelopment #cdc #vaccinesafety #infectiousdisease


Saturday, March 14, 2026, 12:23 am / permalink 20736 / 3 stories in 2 days


A smartphone app can help men last longer in bed / New Scientist

newscientist - In a randomised trial, men who experience premature ejaculation benefitted from using an app to learn techniques for extending intercourse

#healthcare #publichealth #digitalhealth #medicaldevices #behavioralhealth


Saturday, March 14, 2026, 12:23 am / permalink 20735 / 2 stories in 2 days


StackHealth Time Machine




Outgoing Stories


HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 11 stories in 14.8 hours

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 15.8 hours

Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 17.8 hours

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 18.8 hours

FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 30.8 hours

HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 43.8 hours

Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 46.8 hours

Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 47.8 hours

Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 52.8 hours

AI improves UK breast-screening detection by about 10% 5 stories in 52.8 hours


More StackHealth


Bluesky:



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.